NM_018249.6:c.4041G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_018249.6(CDK5RAP2):​c.4041G>A​(p.Leu1347Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.038 in 1,613,676 control chromosomes in the GnomAD database, including 2,718 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.085 ( 1149 hom., cov: 33)
Exomes 𝑓: 0.033 ( 1569 hom. )

Consequence

CDK5RAP2
NM_018249.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.26

Publications

12 publications found
Variant links:
Genes affected
CDK5RAP2 (HGNC:18672): (CDK5 regulatory subunit associated protein 2) This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
CDK5RAP2 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • microcephaly 3, primary, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • corpus callosum, agenesis of
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-120419924-C-T is Benign according to our data. Variant chr9-120419924-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 136706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.26 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5RAP2NM_018249.6 linkc.4041G>A p.Leu1347Leu synonymous_variant Exon 27 of 38 ENST00000349780.9 NP_060719.4 Q96SN8-1B3KVI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5RAP2ENST00000349780.9 linkc.4041G>A p.Leu1347Leu synonymous_variant Exon 27 of 38 1 NM_018249.6 ENSP00000343818.4 Q96SN8-1

Frequencies

GnomAD3 genomes
AF:
0.0849
AC:
12903
AN:
152064
Hom.:
1141
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.226
Gnomad AMI
AF:
0.125
Gnomad AMR
AF:
0.0424
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.0418
Gnomad SAS
AF:
0.00746
Gnomad FIN
AF:
0.0413
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0280
Gnomad OTH
AF:
0.0636
GnomAD2 exomes
AF:
0.0400
AC:
10058
AN:
251472
AF XY:
0.0349
show subpopulations
Gnomad AFR exome
AF:
0.230
Gnomad AMR exome
AF:
0.0258
Gnomad ASJ exome
AF:
0.0172
Gnomad EAS exome
AF:
0.0391
Gnomad FIN exome
AF:
0.0383
Gnomad NFE exome
AF:
0.0285
Gnomad OTH exome
AF:
0.0381
GnomAD4 exome
AF:
0.0331
AC:
48307
AN:
1461494
Hom.:
1569
Cov.:
31
AF XY:
0.0315
AC XY:
22884
AN XY:
727062
show subpopulations
African (AFR)
AF:
0.229
AC:
7658
AN:
33456
American (AMR)
AF:
0.0273
AC:
1222
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0175
AC:
457
AN:
26132
East Asian (EAS)
AF:
0.0692
AC:
2748
AN:
39690
South Asian (SAS)
AF:
0.00764
AC:
659
AN:
86254
European-Finnish (FIN)
AF:
0.0359
AC:
1918
AN:
53420
Middle Eastern (MID)
AF:
0.0522
AC:
301
AN:
5768
European-Non Finnish (NFE)
AF:
0.0277
AC:
30788
AN:
1111674
Other (OTH)
AF:
0.0423
AC:
2556
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2190
4381
6571
8762
10952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1286
2572
3858
5144
6430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0851
AC:
12949
AN:
152182
Hom.:
1149
Cov.:
33
AF XY:
0.0840
AC XY:
6248
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.226
AC:
9367
AN:
41482
American (AMR)
AF:
0.0423
AC:
647
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3472
East Asian (EAS)
AF:
0.0419
AC:
217
AN:
5174
South Asian (SAS)
AF:
0.00685
AC:
33
AN:
4820
European-Finnish (FIN)
AF:
0.0413
AC:
438
AN:
10598
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0281
AC:
1909
AN:
68022
Other (OTH)
AF:
0.0682
AC:
144
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
544
1088
1631
2175
2719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0434
Hom.:
607
Bravo
AF:
0.0930
Asia WGS
AF:
0.0720
AC:
249
AN:
3478
EpiCase
AF:
0.0272
EpiControl
AF:
0.0299

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary Microcephaly, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.10
DANN
Benign
0.48
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6478475; hg19: chr9-123182202; COSMIC: COSV62576900; API